Nature’s Sunshine Announces Stock Offering
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) has made an important announcement regarding a secondary public offering of its common stock. This offering involves the sale of up to 2,854,607 shares of common stock, with the shares being priced at $12.00 each. The offering is part of a stock sale initiated by Fosun Pharma USA, Inc., the selling stockholder, which will receive all net proceeds from the transaction.
Details of the Offering
The anticipated closure of this offering is set for the end of June, contingent upon meeting standard closing conditions. It’s important to note that Nature’s Sunshine itself is not participating in the sale of these shares and will not accrue any proceeds from this public offering.
Costs and Responsibilities
Fosun Pharma USA, Inc. will bear the costs related to underwriting discounts, commissions, and transfer taxes linked to the resale of its shares. Additionally, the company is accountable for some expenses incurred during the registration process of the shares being offered.
Share Repurchase Program
In conjunction with this offering, Nature’s Sunshine has made a conditional agreement with the selling stockholder. This allows for the potential purchase of up to $15.0 million worth of common stock from the underwriters at the public price. However, Nature’s Sunshine has indicated it is not obligated to purchase a minimum quantity, which leaves some uncertainty regarding this aspect.
Role of Underwriters
D.A. Davidson & Co. has taken on the role of the sole book-running manager and will represent the underwriters for this offering. Their expertise will guide the transaction side, ensuring things proceed smoothly.
Regulatory Details
The common stock is available under a shelf registration statement that was filed with the Securities and Exchange Commission (SEC). This filing supports the recent announcement, providing transparency and accessibility for investors.
Company Overview
Nature’s Sunshine Products (NASDAQ: NATR) has established itself as a respected leader in the natural health and wellness sector. Offering a diverse range of high-quality nutritional and personal care products, the company operates in over 40 countries around the globe. Its commitment to quality is exemplified by its state-of-the-art manufacturing facilities, which uphold stringent standards for safety and efficacy.
Company Mission
The company seeks to empower individuals to lead healthier lives by focusing on natural wellness solutions. By continuously adapting to market demands, Nature’s Sunshine is poised to maintain its leadership in the industry.
Investor Relations Information
For those interested in more details regarding the offering or company performance, Nature’s Sunshine encourages investors to reach out via Gateway Group, Inc. Key contact details are as follows:
Cody Slach
1-949-574-3860
NATR@gateway-grp.com
Frequently Asked Questions
What is the main purpose of the stock offering?
The primary purpose is to enable the Selling Stockholder, Fosun Pharma USA, Inc., to liquidate certain shares, with all net proceeds going to them.
How will Nature’s Sunshine use the proceeds from the share repurchase?
Nature’s Sunshine has indicated that any repurchased shares would be funded through cash on hand and possibly its credit facility.
Who is managing the stock offering?
D.A. Davidson & Co. is acting as the sole book-running manager for this secondary public offering.
Is Nature’s Sunshine receiving money from this offering?
No, Nature’s Sunshine is not selling any shares and will not receive proceeds from this offering.
Where can I find more information about Nature’s Sunshine?
Additional details about Nature’s Sunshine Products, including access to investor documents, can be found on their official website.
